Amel Dahmane

Amel Dahmane, PhD, is an accomplished professional with extensive experience in clinical development and project management within the biopharmaceutical industry. Currently serving as Clinical Program Director for Due Diligence and Integration at Ipsen since September 2019, Amel has successfully managed complex Phase I/II studies across multiple countries. Prior experience includes clinical operations management at LFB, where responsibilities encompassed team management, clinical trial setup, and interaction with key stakeholders. Amel's background also includes significant roles at CIS bio international and Therapharm Recherches SAS, with expertise in leading clinical trials, regulatory document preparation, and cross-functional team collaboration. Amel holds a PhD in Biochemistry and a Master's degree in Biochemistry from prestigious Parisian universities.